Medical professionals use CT scans to help diagnose and stage bladder cancer. While CT scans can provide valuable information, they are not perfect and have certain limitations. However, CT scans may ...
"With its potential for screening, recurrence monitoring, treatment guidance, and prognosis prediction, utDNA is poised to transform bladder cancer management and personalize patient care." — Liang ...
Muscle-invasive bladder cancer is an aggressive disease generally treated with cystectomy with or without neoadjuvant therapy. Following curative-intent surgery, about 50% of patients develop ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
Blood- and urine-based ctDNA profiling and monitoring in bladder carcinoma in situ. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include ...
Association of non-luminal subtype with overall survival in high-risk non-muscle invasive bladder cancer patients: Biomarker results from the Bladder Cancer Prognosis Programme. This is an ASCO ...
Doctors use a combination of tests, including urinalysis, cystoscopy, urine culture, and bladder wall biopsy to diagnose interstitial cystitis. For males, they may also examine prostate secretions.
Urology is often perceived in the media as a specialty focused on male health — particularly prostate disease and erectile dysfunction. Yet a large proportion of urological conditions affect women, ...